Adenosine suppresses CW2 human colonic cancer growth by inducing apoptosis via A(1) adenosine receptors

Cancer Lett. 2010 Apr 28;290(2):211-5. doi: 10.1016/j.canlet.2009.09.011. Epub 2009 Oct 12.

Abstract

Extracellular adenosine-induced apoptosis of CW2 human colonic cancer cells by activating caspase-3, -8 and -9, and the effect was enhanced by adding EHNA, an adenosine deaminase inhibitor. Adenosine-induced CW2 cell death was inhibited by 8-CPT, an A(1) adenosine receptor inhibitor, but otherwise 2-chloroadenosine, an A(1) adenosine receptor agonist, and MDL-12330A, an inhibitor of adenylate cyclase, mimicked the adenosine effect. For mice inoculated with CW2 cells, intraperitoneal injection with adenosine reduced tumor growth and more prominent reduction was obtained with co-injection with EHNA. Adenosine, thus, suppresses CW2 human colonic cancer growth by inducing apoptosis as mediated via A(1) adenosine receptors.

MeSH terms

  • Adenosine / pharmacology*
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Caspases / drug effects
  • Caspases / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Colonic Neoplasms / metabolism
  • Colonic Neoplasms / pathology*
  • Enzyme Activation / drug effects
  • Humans
  • Mice
  • Receptor, Adenosine A1 / drug effects*
  • Receptor, Adenosine A1 / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • Receptor, Adenosine A1
  • Caspases
  • Adenosine